Mobile

A 24 week multinational multi-center study consisting of a 12-week single blind study to evaluate the efficacy and safety of methotrexate versus Azathioprin treatment in adult patients with chronic se...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-011132-34

A 24 week multinational multi-center study consisting of a 12-week single blind study to evaluate the efficacy and safety of methotrexate versus Azathioprin treatment in adult patients with chronic severe atopic dermatitis (AD) and a 12-week follow up period

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the efficacy of methotrexate versus azathiorpine treatment in adult patients with chronic severe AD.

Critère d'inclusion

  • Patients with severe atopic dermatitis, defined as a score of 8-9 on the Rajka and Langeland criteria who are unresponsive, intolerant or contra-indicated to cyclisporin treatment

Liens